Literature DB >> 3539811

Transmission of human immunodeficiency virus (HIV/HTLV-III/LAV): a review.

M van der Graaf, R J Diepersloot.   

Abstract

The literature on the transmission of human immunodeficiency virus (HIV/HTLV-III/LAV) is reviewed. HIV spreads by vertical transmission and by iatrogenic transmission (transfer of blood or blood-containing products), by infected needles among i.v. drug users and, more rarely, among health care workers, but mainly by sexual contact. In Western countries the virus is mainly spread by passive anal intercourse among homosexuals and seldom by heterosexual intercourse. In African countries, however, the virus is mainly spread by heterosexual intercourse, probably because of other, concurring sexually transmitted diseases. Some preventive measures are discussed.

Entities:  

Keywords:  Africa; Antibodies--analysis; Behavior; Biology; Delivery Of Health Care; Developed Countries; Developing Countries; Diseases; Health; Health Personnel; Hematological Effects; Hemic System; Heterosexuals; Hiv Infections--prevention and control; Hiv Infections--transmission; Homosexuals; Immunity; Immunologic Factors; Literature Review; Physiology; Sex Behavior; Social Problems; Substance Addiction; Viral Diseases

Mesh:

Year:  1986        PMID: 3539811     DOI: 10.1007/BF01644263

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  96 in total

1.  Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.

Authors:  J R Robertson; A B Bucknall; P D Welsby; J J Roberts; J M Inglis; J F Peutherer; R P Brettle
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

2.  Antibodies to human T-cell lymphotropic virus type III in promiscuous healthy homosexual men. Relation to immunological and clinical findings.

Authors:  J Gerstoft; B O Lindhardt; C S Petersen; S Kroon; S Ullman; S Møller; J O Nielsen; E Dickmeiss
Journal:  Eur J Clin Invest       Date:  1985-10       Impact factor: 4.686

3.  [Incidence of HTLV-III antibodies in blood donors at the German Red Cross].

Authors:  B Kubanek; K Koerner
Journal:  Dtsch Med Wochenschr       Date:  1986-03-28       Impact factor: 0.628

4.  Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-09-20       Impact factor: 17.586

5.  Prevalence of anti-HTLV-III in UK risk groups 1984/85.

Authors:  W J Jesson; R W Thorp; P P Mortimer; J K Oates
Journal:  Lancet       Date:  1986-01-18       Impact factor: 79.321

6.  Heterosexual promiscuity among African patients with AIDS.

Authors:  N Clumck; P Van de Perre; M Caral; D Rouvroy; D Nzaramba
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

7.  Seroconversion of human T cell lymphotrophic virus III (HTLV-III) in patients with haemophilia: a longitudinal study.

Authors:  S E Ball; J M Hows; A M Worsley; L Luzzatto; A C Chu; R Meacham; J Morris; R Cheingsong-Popov; R A Weiss; R Tedder
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

8.  Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.

Authors:  J J Goedert; M G Sarngadharan; M E Eyster; S H Weiss; A J Bodner; R C Gallo; W A Blattner
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

9.  Acquired immunodeficiency syndrome in a heterosexual population in Zaire.

Authors:  P Piot; T C Quinn; H Taelman; F M Feinsod; K B Minlangu; O Wobin; N Mbendi; P Mazebo; K Ndangi; W Stevens
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

10.  HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.

Authors:  M Melbye; K S Froebel; R Madhok; R J Biggar; P S Sarin; S Stenbjerg; G D Lowe; C D Forbes; J J Goedert; R C Gallo
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

View more
  3 in total

1.  Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure.

Authors:  R A Tange; D Troost; M Limburg
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  HIV-specific antibody among voluntary blood donors in Lower Saxony (FRG).

Authors:  G Caspari; J Beyer; F Schunter; J Knüver-Hopf; H Schmitt
Journal:  Blut       Date:  1987-09

Review 3.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.